Phocas Financial Corp. - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 203 filers reported holding IMPAX LABORATORIES INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
Phocas Financial Corp. ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q1 2016$4,616,000
-28.1%
144,159
-4.0%
0.35%
-29.8%
Q4 2015$6,423,000
+30.7%
150,212
+7.6%
0.50%
+21.4%
Q3 2015$4,914,000
-17.8%
139,566
+7.3%
0.42%
-14.3%
Q2 2015$5,975,000
-5.3%
130,124
-3.3%
0.48%
-3.4%
Q1 2015$6,308,000
+77.4%
134,584
+19.9%
0.50%
+61.6%
Q4 2014$3,555,000112,2120.31%
Other shareholders
IMPAX LABORATORIES INC shareholders Q2 2016
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 560,400$9,022,0003.93%
NORTH TIDE CAPITAL, LLC 1,000,000$16,100,0003.58%
Sivik Global Healthcare LLC 250,000$4,025,0001.47%
MAVERICK CAPITAL LTD 7,159,336$115,265,0001.44%
SECTOR GAMMA AS 589,311$9,488,0001.38%
BRIDGER MANAGEMENT, LLC 1,341,143$21,592,0001.23%
Eos Focused Equity Management, L.P. 48,714$784,0000.89%
Bridge City Capital, LLC 47,194$760,0000.64%
Fosun International Ltd 300,000$4,830,0000.60%
Century Capital Management, LLC 203,138$3,271,0000.56%
View complete list of IMPAX LABORATORIES INC shareholders